BUSINESSFINANCIAL TIMES WORLD
Brussels launches antitrust probe into French drugmaker Sanofi
Brussels has launched an antitrust probe into French drugmaker Sanofi, investigating whether the company conducted a misleading campaign against a rival flu vaccine manufacturer. The competition watchdog is examining potential anticompetitive practices related to flu vaccines.
Related Signal
Adjacent reporting
- EU hits France's Sanofi with flu vaccine antitrust probe
- US launches Germany pharma pricing probe, raising threat of new tariffs
- Microsoft could be the next Big Tech antitrust target
- UK antitrust regulator is officially investigating Microsoft Office
- DOJ investigating meatpacking companies after Trump price manipulation allegations